KeyCorp Cuts HCA Healthcare (NYSE:HCA) Price Target to $420.00

HCA Healthcare (NYSE:HCA) had its price target cut by KeyCorp from $475.00 to $420.00 in a research report sent to investors on Monday, Benzinga reports. They currently have an overweight rating on the stock.

A number of other analysts also recently weighed in on HCA. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Oppenheimer lifted their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Morgan Stanley began coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Leerink Partners increased their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Finally, Barclays upped their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $379.11.

HCA Healthcare Stock Up 0.1 %

Shares of HCA opened at $361.08 on Monday. The business’s 50 day simple moving average is $394.11 and its 200-day simple moving average is $353.54. HCA Healthcare has a 1 year low of $223.73 and a 1 year high of $417.14. The stock has a market capitalization of $94.57 billion, a price-to-earnings ratio of 18.00, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.73%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC lifted its holdings in shares of HCA Healthcare by 26.2% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 2,703 shares of the company’s stock valued at $1,099,000 after buying an additional 561 shares during the period. Hixon Zuercher LLC purchased a new position in HCA Healthcare in the third quarter valued at $2,356,000. ASB Consultores LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $210,000. First National Bank of Mount Dora Trust Investment Services boosted its position in HCA Healthcare by 4.7% during the third quarter. First National Bank of Mount Dora Trust Investment Services now owns 8,078 shares of the company’s stock worth $3,283,000 after purchasing an additional 366 shares in the last quarter. Finally, Garrison Asset Management LLC increased its position in shares of HCA Healthcare by 7.0% in the third quarter. Garrison Asset Management LLC now owns 722 shares of the company’s stock valued at $293,000 after buying an additional 47 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.